While our study addressing potential effects of clinical-grade human ABCB5+ MSCs in a therapeutic rat model of cisplatin-induced AKI revealed no clinical amelioration of kidney injury, this cell population exerted pro-regenerative and immunomodulatory effects on recipients at the mRNA expression level. This evidence concerns the gene ABCB5 and acute kidney injury.